| Execution period | 3 years |
|---|
BSE filing, NSE: PRAXIS. Summary written from the filing by ALFA Finder's alert engine.
Praxis Home Retail Ltd: key numbers
- Share price
- ₹3.86
- Market cap
- ₹71.38 Cr
- Revenue (annual)
- ₹95.66 Cr
- Net profit (annual)
- ₹-66.62 Cr
- P/E (TTM)
- -1.2×Sector 61.5×
- Promoter holding
- 7.23%+0.00% QoQ
- FII holding
- 1.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Praxis Home Retail Ltd
All →Praxis Home Retail Debt & Borrowing: ₹2 Cr
Praxis Home Retail availed a ₹2 Crore unsecured inter-corporate loan from I-3PL (India) at 13% p.a. for 3 months. The RPT finances working capital and general corporate purposes.
- Value
- ₹2.00 Cr
- Execution
- 3 months (subject to mutual written agreement for extension)
Praxis Home Retail Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Praxis Home Retail Board Meeting Date
Praxis Home Retail scheduled its board meeting for 05 Nov 2026 to approve unaudited Q2/H1 results. No financial figures or material decisions are disclosed in this intimation.
Praxis Home Retail Debt & Borrowing: ₹2.5 Cr
Praxis Home Retail Limited secured an unsecured inter-corporate loan of ₹2.50 Crore from Matrix Park Private Limited for working capital and general corporate purposes.
- Value
- ₹2.50 Cr
- Execution
- until March 31, 2027
Praxis Home Retail Debt & Borrowing: ₹3.5 Cr
Praxis Home Retail Limited has entered into a loan agreement with Matrix Park Private Limited to avail an unsecured inter-corporate loan of ₹3.50 Crore.
- Value
- ₹3.50 Cr
- From
- Matrix Park Private Limited
Praxis Home Retail Employee Stock Options
Praxis Home Retail Ltd amended its Employee Stock Option Plan 2024, increasing the ESOP pool size from 30,00,000 to 65,00,000 options.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.